December 4, 2015

December 04, 2015

Breaking down research barriers in cancer metabolism
International Innovation - Dec. 3
A group of researchers at Moffitt Cancer Center in Florida is investigating cancer metabolism to improve understanding of the disease. One of the team’s main programmes of research is determining ways to stifle fat producing pathways, to limit the progression of tumours

University Area hopes innovation alliance leads to greater promise
Tampa Bay Times – Dec. 3
Comprising the area's anchor institutions — USF, Moffitt Cancer Center, Florida Hospital, Busch Gardens and RD Development, owners of the University Mall — and guided by former county commissioner Mark Sharpe, the alliance's goal is to attract new business to the area and create an innovation hub in North Tampa.

Color Cancer screenings
WSB-AM (Atlanta) – Dec. 3        
Colon cancer is the 2nd leading cause of death in America. For African Americans it is even more deadly. But doctors at Moffitt Cancer Center in Tampa Florida say it doesn’t have to be a death sentence.

Solution needed to provide basic treatment to serious diseases for uninsured in Hernando
Tampa Bay Times –Dec. 2
Without a breast biopsy confirmation, she can't go to Moffitt Cancer Center in Tampa, where she could get the needed treatment for free.

 

Immuno-Oncology 360, Feb. 2-3, 2016, New York

Medical News Today – Dec. 2

Jeffrey Weber, MD, PhD, Senior Member and Director Donald A Adam Comprehensive Melanoma Research Center, Moffitt Cancer Center

Ampliemos la dispondibilidad de la telemedicine
AARP Florida – Dec. 2
En el Moffitt Cancer Center de Tampa, los médicos ayudan a pacientes de todo el mundo sin salir de sus consultorios. Analizan láminas de histopatología, brindan una segunda opinión y recomiendan tratamientos, todo por videoconferencia en línea.

FDA Approves First Oncolytic Virus Therapy: Imlygic for Melanoma
Oncology Times
“This is another possible way of treating a patient's recurrent unresectable melanoma with minimal side effects through a different avenue,” the trial's principal investigator Jonathan Zager, MD, FACS, Chair of Graduate Medical Education, a surgical oncologist and Senior Member in the Departments of Cutaneous Oncology and Sarcoma and Director of Regional Therapies at the Donald A. Adam Comprehensive Melanoma Research Center of Excellence, all at Moffitt Cancer Center, said in a news release.

Lenalidomide plus rituximab produces durable responses in mantle cell lymphoma patients
Pharmacy Choice – Dec. 2
New research from Moffitt Cancer Center and its collaborators find that the drug combination rituximab plus lenalidomide was effective and produced long-term responses in patients with mantle cell lymphoma. The results from the multicenter phase 2 study were published in the Nov. 5 issue of The New England Journal of Medicine (see also Lymphoma).

New treatment option for two types of soft-tissue sarcomas
Pharmacy Today – Dec. 1
“Yondelis brings options to patients with liposarcoma, who before had very few pharmacologic options and generally didn’t respond well to chemotherapy, and to patients with leiomyosarcoma, who would face the challenges of dacarbazine therapy,” Christine Walko, PharmD, BCOP, personalized medicine specialist at the Moffitt Cancer Center in Tampa, FL, told Pharmacy Today.

First oncolytic virus vaccine for advanced melanoma
Pharmacy Today – Dec. 1
“Imlygic is a unique melanoma treatment in that it has to be injected directly into the melanoma lesions themselves. Even though patients won’t have all of their lesions injected, even noninjected lesions can respond to the drug,” said Christine Walko, PharmD, BCOP, personalized medicine specialist at the Moffitt Cancer Center in Tampa, FL.

The Other Side of the Valley: 3,434 Days and Counting
Cure Magazine “Kevin Berry blog” – Dec. 1
My wife and I recently attended an amazing event. Moffitt Cancer Center in Tampa holds a bi-annual transplant survivor’s reunion. This year, over 250 patients along with family members, doctors, nurses and other staff gathered in a huge ballroom in a joyous celebration of survival.

Making Telehealth more available
AARP Bulletin – Dec. 1
At Moffitt Cancer Center in Tampa, doctors confer with patients around the world without leaving the office. They examine pathology slides, offer second opinions and recommend treatment—all through online videoconferencing.

Testing Immunotherapies in Brain Cancer Requires Careful Management of Toxicities
Cure Magazine – Nov. 30
In fact, many lessons can be gleaned from his extensive clinical experience with immunotherapies in the melanoma setting; Weber has studied them since 2002, first at the Moffitt Cancer Center, and most recently, as deputy director of the Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center.

Prescient appoints Dr Lancet to SAB
Herald Sun (Melbourne, Australia) – Nov. 30
PRESCIENT Therapeutics has appointed Professor Jeffrey Lancet of H. Lee Moffitt Cancer Center to its scientific advisory board.

Radiology conference offers HealthMyne a chance to boost its image
WisBusiness.com – Nov. 30
HealthMyne closed a $4.5 million fundraising round earlier this year led by Madison-based funds Venture Investors and 4490 Ventures, and it has tested its product at UW Health and at the Moffitt Cancer Center in Florida.

Testing Immunotherapies in Brain Cancer Requires Careful Management of Toxicities
CureToday – Nov. 30
In fact, many lessons can be gleaned from his extensive clinical experience with immunotherapies in the melanoma setting; Weber has studied them since 2002, first at the Moffitt Cancer Center, and most recently, as deputy director of the Laura and Issac Perlmutter Cancer Center at NYU Langone Medical Center.

Facing Cancer: A veteran educator imparts hard-learned lessons
NJ.com – Nov. 30
He also completed his internal medicine residency at the University of South Florida, and completed his fellowship in medical oncology and hematology at the university-affiliated H. Lee Moffitt Cancer Center and Research Institute in Tampa. 

Prostate Cancer Treatment Information
WLFA - Nov. 29
At Moffitt Cancer Center, we take a unique, multispecialty approach to treating prostate cancer. 

Margarita Romo honored as lightning community hero
Lightning.NHL.com – Nov. 28
The clinic partners with the Moffitt Cancer Center and provides farmworkers with cancer information, screening and resources. The partnership includes collaboration with Moffitt’s Tampa Bay Community Cancer Network (TBCCN) that includes over 20 other organizations in the area.

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.